S. RUBINRAUT

657 total citations
18 papers, 548 citations indexed

About

S. RUBINRAUT is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, S. RUBINRAUT has authored 18 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in S. RUBINRAUT's work include Neuropeptides and Animal Physiology (9 papers), Chemical Synthesis and Analysis (3 papers) and Protein Hydrolysis and Bioactive Peptides (3 papers). S. RUBINRAUT is often cited by papers focused on Neuropeptides and Animal Physiology (9 papers), Chemical Synthesis and Analysis (3 papers) and Protein Hydrolysis and Bioactive Peptides (3 papers). S. RUBINRAUT collaborates with scholars based in Israel and United States. S. RUBINRAUT's co-authors include Mati Fridkin, Illana Gozes, Douglas E. Brenneman, Ayelet Reshef, Amos Bardea, Ariane Davidson, Rachel Zamostiano, E. Giladi, Israel Ashkenazi and Robert I. Glazer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Endocrinology.

In The Last Decade

S. RUBINRAUT

18 papers receiving 533 citations

Peers

S. RUBINRAUT

CMN

PHYSI

ONCOL

SURGE

Seema Tevar United States

Marie‐Noëlle Castel France

Patrick Mouchet France

Jakob Lindberg Sweden

Jonathan D. Kursar United States

Filip Dumont Belgium

Claudia De Mei Italy

Jean‐Claude Beaujouan France

Steven Guard United Kingdom

Laurence Desrues France

Seema Tevar United States

S. RUBINRAUT

604 ×1.8

CMN

322 ×1.0

106 ×1.3

PHYSI

43 ×0.6

ONCOL

26 ×0.5

SURGE

Citations per year, relative to S. RUBINRAUT S. RUBINRAUT (= 1×) peers Seema Tevar

Countries citing papers authored by S. RUBINRAUT

Since Specialization

Citations

This map shows the geographic impact of S. RUBINRAUT's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. RUBINRAUT with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. RUBINRAUT more than expected).

Fields of papers citing papers by S. RUBINRAUT

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. RUBINRAUT. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. RUBINRAUT. The network helps show where S. RUBINRAUT may publish in the future.

Co-authorship network of co-authors of S. RUBINRAUT

This figure shows the co-authorship network connecting the top 25 collaborators of S. RUBINRAUT. A scholar is included among the top collaborators of S. RUBINRAUT based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. RUBINRAUT. S. RUBINRAUT is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

RUBINRAUT, S., et al.. (2009). The amyloidogenic domains of the human serum amyloid A protein -New Insights-. Advances in experimental medicine and biology. 611. 69–70. 1 indexed citations

Sasson, Keren, et al.. (2009). Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditions. Journal of Controlled Release. 142(2). 214–220. 12 indexed citations

Shechter, Yoram, S. RUBINRAUT, Haim Tsubery, et al.. (2008). Reversible pegylation of insulin facilitates its prolonged action in vivo. European Journal of Pharmaceutics and Biopharmaceutics. 70(1). 19–28. 27 indexed citations

Gozes, Illana, Ariane Davidson, Amos Bardea, et al.. (2006). Development of VIP Agonists and Antagonists with Tissue and Receptor Specificity: Effects on Behavioral Maturation, Sexual Function, and the Biologic Clocka. Annals of the New York Academy of Sciences. 805(1). 159–169. 2 indexed citations

Shechter, Yoram, Eytan Gershonov, Keren Sasson, et al.. (2006). New Technologies to Prolong Life-time of Peptide and Protein Drugs In vivo. International Journal of Peptide Research and Therapeutics. 13(1-2). 105–117. 19 indexed citations

Gozes, Illana, Orly Perl, E. Giladi, et al.. (1999). Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: Neuroprotective drug design. Proceedings of the National Academy of Sciences. 96(7). 4143–4148. 49 indexed citations

Gozes, Illana, Amos Bardea, M. Bechar, et al.. (1997). Neuropeptides and Neuronal Survival: Neuroprotective Strategy for Alzheimer's Disease^a. Annals of the New York Academy of Sciences. 814(1). 161–166. 16 indexed citations

Gozes, Illana, Michal Bachar, Amos Bardea, et al.. (1997). Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: Implications for early treatment of Alzheimer's disease. Journal of Neurobiology. 33(3). 329–342. 51 indexed citations

Giladi, E., Ariane Davidson, Michal Bachar, et al.. (1997). Protection against developmental and learning impairments in apolipoprotein e-deficient mice by activity-dependent femtomolar-acting peptides. Neuroscience Letters. 237. S19–S19. 2 indexed citations

10.

Gozes, Illana, Amos Bardea, Ayelet Reshef, et al.. (1996). Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.. Proceedings of the National Academy of Sciences. 93(1). 427–432. 156 indexed citations

11.

Gozes, Illana, Robert I. Glazer, Israel Ashkenazi, et al.. (1995). Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors.. Journal of Pharmacology and Experimental Therapeutics. 273(1). 161–167. 93 indexed citations

12.

Wollman, Yoram, Milton N. Goldstein, S. RUBINRAUT, et al.. (1994). Inhibition of human neuroblastoma growth by a specific VIP antagonist. Journal of Molecular Neuroscience. 5(4). 231–239. 37 indexed citations

13.

Gozes, Illana, et al.. (1994). Stearyl-norleucine-vasoactive intestinal peptide (VIP): a novel VIP analog for noninvasive impotence treatment.. Endocrinology. 134(5). 2121–2125. 48 indexed citations

14.

RUBINRAUT, S., et al.. (1990). Thiolysis of the 3‐nitro‐2‐pyridinesulfenyl (Npys) protecting group An approach towards a general deprotection scheme in peptide synthesis. International journal of peptide & protein research. 35(6). 545–549. 10 indexed citations

15.

RUBINRAUT, S., et al.. (1985). Reactions of hexamethylbenzene adsorbed on silica gel and Florisil with ozone and with oxygen species formed on microwave discharge of oxygen. The Journal of Organic Chemistry. 50(15). 2647–2649. 6 indexed citations

16.

RUBINRAUT, S., et al.. (1985). ChemInform Abstract: REACTIONS OF DI‐, TRI‐, AND HEXAMETHYLBENZENES WITH OXYGEN(3P) ATOMS IN LIQUID AND ON ADSORBED PHASES. Chemischer Informationsdienst. 16(34). 2 indexed citations

17.

RUBINRAUT, S., et al.. (1985). Reactions of di-, tri-, and hexamethylbenzenes with oxygen(3P) atoms in liquid and on adsorbed phases. Journal of the American Chemical Society. 107(8). 2489–2494. 13 indexed citations

18.

FEIT, B. A., et al.. (1976). Vinyl carbanions. Part I. Kinetics of hydrogen–deuterium exchange in fluoren-9-ylideneacetonitrile catalysed by sodium ethoxide. Journal of the Chemical Society Perkin Transactions 2. 253–256. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact